WALDENSTROM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTROM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in controlling rare blood cancer and harvesting stem cells
Disease control OngoingThis study tests whether the drugs bortezomib and rituximab can help control Waldenstrom's macroglobulinemia, a rare blood cancer. About 46 people who have not had prior treatment will receive the combination. The goal is to shrink the cancer and collect stem cells that could be …
Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Scientists launch tissue bank to unlock secrets of rare blood cancers
Knowledge-focused OngoingThis study collects bone marrow and blood samples, along with medical history, from people with multiple myeloma, Waldenstrom macroglobulinemia, and related disorders. The samples are stored in a tissue bank for future research to understand what causes these cancers, how they pr…
Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:07 UTC